31 results
S-3ASR
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Automatic shelf registration
4:45pm
in the period ended December 31, 2023 and management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2023
8-K
EX-99.3
CRNX
Crinetics Pharmaceuticals Inc
3 Jun 24
Regulation FD Disclosure
4:35pm
: Change from baseline in morning serum 17-OHP at week 12 Primary Safety Assessment: Incidence of TEAEs throughout the study A4: Androstenedione; ULN … no height assessment at baseline and was excluded in the summary. ** Central laboratory data reported. 2 participants entered the 11 study based
S-3ASR
CRNX
Crinetics Pharmaceuticals Inc
19 Mar 24
Automatic shelf registration
4:05pm
Pharmaceuticals, Inc. as of December 31, 2023 and 2022 and for each of the three years in the period ended December 31, 2023 and management’s assessment
424B5
xn13tddoa7 dr6s34wk
13 Sep 23
Prospectus supplement for primary offering
5:19pm
424B5
icns9a 3wycm4vr7h
11 Sep 23
Prospectus supplement for primary offering
4:09pm